BioSpace News Archive

Spinal Elements, a spine technology company, today announced the first 510(k) clearance in the Lucent® 3D line of 3D-printed interbody devices. In developing Lucent 3D, Spinal Elements has taken advantage of the unique capabilities of 3D printing by printing a functionally unique multi-component device in a single printing step

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2021 before the US financial markets open on May 3, 2021.

OS Therapies, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS) and other deadly cancers in kids and adults including ovarian, esophageal, endometrial and lung cancers, today announced the closing of a $6 million Series A round of funding.

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division has renewed licenses to its DILIsym® software platform, its flagship quantitative systems toxicology (QST) software for predicting and investigating drug-induced liver injury (DILI), for use by the U.S. Food and Drug Administration (FDA).

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it will host a live webcast of its second quarter fiscal 2021 conference call on Wednesday, April 28, at 7:30 a.m. CT (8:30 a.m. ET).

Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2021 following the close of regular trading on Tuesday, May 4, 2021. The earnings news release will be followed by a conference call at 3:00 p.m. Mountain Time that day.

SANUWAVE Health, Inc., focused on the development and commercialization of a robust and innovative advanced wound care product portfolio for the repair and regeneration of skin and vascular structures, announced its rebranding.

Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services , today announced Tony Bower has joined as a Vice President in its Life Sciences practice. Dr. Bower will be based in CRA’s San Francisco office.

Iconic Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to translating an understanding of Tissue Factor (TF) biology to new therapeutics for cancer, retinal disease and inflammation, today announced that Dirk Sauer, Ph.D., former Novartis Pharma AG’s Global Development Unit Head, Ophthalmology, has joined the company

Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, announced today the addition of three independent directors to its board. New directors comprise Troy Cox, former CEO of Foundation Medicine, Susannah Gray, former EVP and CFO of Royalty Pharma Management, and Karen McGinnis, former VP and CAO of Illumina.